Want to join the conversation?
Goldman Sachs analyst Patrick Archambault questions $AN whether it is identifying more stop-sale inventory because of identifying VIN numbers. CEO Mike Jackson says that the devices are beginning to arrive and so with certain manufacturers, it can batch order device and not go VIN by VIN.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?